指南与共识姑息放疗与转移瘤放疗物理与技术

脊柱与非脊柱骨转移立体定向体部放疗推荐:GETUG基于全国两轮改良德尔菲调查的共识

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.
指南 / 共识 · Clin Transl Radiat Oncol · 2022-08-08

法国泌尿肿瘤放射治疗学会(GETUG)针对脊柱骨转移(SBM)与非脊柱骨转移(NSBM)的立体定向体部放疗(SBRT)制定共识指南。经文献综述形成97条推荐声明,由29名专家中21名(72.4%)完成两轮改良德尔菲调查,最终91/97条(93.8%)达成共识。共识将作为GETUG临床试验的方案推荐使用。

要点

  • GETUG采用两轮改良德尔菲法就SBM与NSBM的SBRT形成97条推荐声明。
  • 最终91/97条(93.8%)达成共识,16条经第二轮投票达成共识、5条呈共识趋势。
  • 未达成共识的声明涉及患者选择、剂量分割、处方与剂量目标及危及器官勾画。

核心结论

  • 采用经验证的改良德尔菲方法就SBM与NSBM的SBRT达成共识指南,将作为正在开展及后续GETUG临床试验的方案推荐使用。

研究设计与样本

  • GETUG在全面文献综述后创建97条关于SBM与NSBM SBRT计划与实施的推荐声明。
  • 声明提交给GETUG主要研究者进行全国在线两轮改良德尔菲调查,共识定义为同意率≥75%,共识趋势定义为同意率65-74%。
  • 第一轮未达成共识的声明在第二轮重新提交。

主要发现

  • 29名受邀专家中21名(72.4%)完成两轮调查。
  • 第一轮75条声明达成共识,剩余22条需重新投票,其中16条达成共识、5条呈共识趋势。
  • 最终共识率为91/97条(93.8%)。
  • 未达成共识的声明涉及患者选择(3/19)、剂量与分割(1/11)、处方与剂量目标(1/9)及危及器官勾画(1/15)。

关键数值与推荐

  • 共识定义为声明获得≥75%的同意率,共识趋势定义为65-74%的同意率。
  • 最终91/97条(93.8%)声明达成共识,未达成共识的声明涉及患者选择(3/19)、剂量与分割(1/11)、处方与剂量目标(1/9)及危及器官勾画(1/15)。

临床怎么用

  • 原文未据此给出推荐,共识指南将作为正在开展及后续GETUG临床试验的方案推荐使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The relevance of metastasis-directed stereotactic body radiation therapy (SBRT) remains to be demonstrated through phase III trials. Multiple SBRT procedures have been published potentially resulting in a disparity of practices. Therefore, the french society of urological radiation oncolgists (GETUG) recognized the need for joint expert consensus guidelines for metastasis-directed SBRT in order to standardize practice in trials carried out by the group. MATERIALS AND METHODS: After a comprehensive literature review, 97 recommendation statements were created regarding planning and delivery of spine bone (SBM) and non-spine bone metastases (NSBM) SBRT. These statements were then submitted to a national online two-round modified Delphi survey among main GETUG investigators. Consensus was achieved if a statement received ≥ 75 % agreements, a trend to consensus being defined as 65-74 % agreements. Any statement without consensus at round one was re-submitted in round two. RESULTS: Twenty-one out of 29 (72.4%) surveyed experts responded to both rounds. Seventy-five statements achieved consensus at round one leaving 22 statements needing a revote of which 16 achieved consensus and 5 a trend to consensus. The final rate of consensus was 91/97 (93.8%). Statements with no consensus concerned patient selection (3/19), dose and fractionation (1/11), prescription and dose objectives (1/9) and organs at risk delineation (1/15). The voting resulted in the writing of step-by-step consensus guidelines. CONCLUSION: Consensus guidelines for SBM and NSBM SBRT were agreed upon using a validated modified Delphi approach. These guidelines will be used as per-protocole recommendations in ongoing and further GETUG clinical trials.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Vilotte F, Pasquier D, Blanchard P, et al. Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey. Clin Transl Radiat Oncol. 2022. PMID: 36052019. doi:10.1016/j.ctro.2022.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。